Who Paid My Doc
Acp-044-005
ClinicalTrials.gov NCT05008835
Research payments
$1,874,899
Through program year 2023, $1,874,899 in research payments was reported against Acp-044-005, across 276 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT05008835
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $238,393 | 59 |
| 2022 | Research | $1,365,134 | 185 |
| 2021 | Research | $271,372 | 32 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Hermann Danville, VA Named on 12 payments
- Robert Molpus Longwood, FL Named on 12 payments
- Hanid Audish Spring Valley, CA Named on 10 payments
- Stacey Layle San Diego, CA Named on 10 payments
- Alexander Dela Llana Evansville, IN Named on 10 payments
- George Freeman Newport News, VA Named on 9 payments
- Ronald Stumbris Palos Heights, IL Named on 9 payments
- John Joyce Jacksonville, FL Named on 8 payments
- Hayes Williams Vestavia, AL Named on 8 payments
- Lora McGill Memphis, TN Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.